Canetti, Michal http://orcid.org/0000-0001-5235-3447
Barda, Noam http://orcid.org/0000-0002-3400-235X
Gilboa, Mayan
Indenbaum, Victoria
Mandelboim, Michal
Gonen, Tal
Asraf, Keren
Weiss-Ottolenghi, Yael
Amit, Sharon
Doolman, Ram
Mendelson, Ella
Harats, Dror
Freedman, Laurence S. http://orcid.org/0000-0002-6767-7900
Kreiss, Yitshak
Lustig, Yaniv
Regev-Yochay, Gili http://orcid.org/0000-0001-7163-4607
Article History
Received: 8 July 2022
Accepted: 5 December 2022
First Online: 13 December 2022
Change Date: 22 March 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-023-37338-7
Competing interests
: G.R.Y. reports institutional grant funding of studies not related to the current study from Pfizer, consulting/honoraria from Teva, MSD, Astrazeneca, Pfizer, and Moderna. N.B. and Y.L. report an institutional grant from Pfizer. All other authors report no competing interests.